Skip to content

Main Navigation

Fennec Pharmaceuticals
Fennec Pharmaceuticals
  • About Us
    • Our Mission
    • Our Team
  • Our Focus
    • Cisplatin-Induced Hearing Loss
    • Publications & Presentations
  • Our Pipeline
  • For Families
    • Advocacy Groups
    • Family Stories
    • Named Patient Access
  • For Investors
    • Corporate Profile
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
  • Contact Us
  • About Us
    • Our Mission
    • Our Team
  • Our Focus
    • Cisplatin-Induced Hearing Loss
    • Publications & Presentations
  • Our Pipeline
  • For Families
    • Advocacy Groups
    • Family Stories
    • Named Patient Access
  • For Investors
    • Corporate Profile
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
  • Contact Us

Helping the kids of today become the adults of tomorrow

Fennec Pharmaceuticals is a late-stage biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.

Discover what we stand for
Explore what we’re focused on
Learn about our pipeline

Latest News

  • Fennec Pharmaceuticals Announces Up to $45 Million Investment From PetrichorAugust 1, 2022
  • Fennec Announces Results of Annual MeetingJune 17, 2022
  • FENNEC PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESMay 23, 2022
See More

Resources

For Investors
For Families

Fennec® is a registered trademark of Fennec Pharmaceuticals Inc.
© 2020 Fennec Pharmaceuticals. All rights reserved. US-FENPED20-41 11/20

  • Privacy Policy
  • Terms & Conditions
  • Careers
  • Sitemap